EMA launches Website for accelerating EU Clinical Trials
Recommendation
22/23 October 2024
Register now for ECA's GMP Newsletter
The EMA has launched a dedicated website for the Accelerating clinical trials in the European Union (ACT EU) initiative, co-led by the European Commission, the Heads of Medicines Agencies and the European Medicines Agency (EMA). The website contains updates on the progress of ACT EU priority actions, which aim to improve the clinical trials environment in the EU through harmonization, innovation, and stakeholder collaboration.
Key resources include latest information on:
- the Multi-stakeholder platform;
- the implementation of the Clinical Trials Regulation (CTR);
- voluntary procedures in scientific advice;
- the Simultaneous national scientific advice (SNSA) pilot.
In addition, the EMA held a workshop on establishing a multi-stakeholder platform on 22/23 June 2023. Following the workshop, the presentations shown and also the video recordings were published on the EMA website about the workshop.
Related GMP News
05.09.2024Clinical Trials Regulation - Version 6.9 of the Q&As
23.07.2024Pilot Results on Regulatory-Led RWE Generation
23.07.2024ICH M12 Guideline on Drug Interaction Studies
20.06.2024Draft ICH M14 Guideline on Real-World Data for Safety Assessment
20.06.2024Glossary of Terms and Definitions for Innovative Clinical Trials
21.05.2024Real-World Evidence: FDA´s Considerations for Non-Interventional Studies